Self-reported Headache Among the Employees of a Swiss University Hospital: Prevalence, Disability, Current Treatment, and Economic Impact

Overview

Journal J Headache Pain

Publisher Biomed Central

Date 2013 Apr 10

PMID 23565579

Citations 12

Authors

Emina Sokolovic

Franz Riederer

Thomas Szucs

Reto Agosti

Peter Stefan Sandor

Affiliations

Soon will be listed here.

Abstract

Background: The objectives of this cross-sectional, observational study were to determine the prevalence of self-reported headache among the employees of the large Swiss university hospital, to measure the impact of headache using the MIDAS questionnaire, to assess current treatment and to estimate economic burden of headache considering indirect costs.

Methods: A self-administered questionnaire was distributed internally to 2000 randomly selected employees of the University Hospital Zurich.

Results: 1210 employees (60.5%) responded. Of the 1192 (98.5%) employees who provided sufficiently complete information, 723 (61%) reported at least one headache type in the last three months. The prevalence of migraine, and tension-type headache was 20% and 50%, respectively. Regarding the occupational groups, there was a trend that healthcare staff, administration employees, and medical technicians suffered more from headaches than physicians, correcting for age and sex. The economic consequences of lost productivity were calculated to amount to approximately 14 million Swiss Francs (9.5 million EUR), representing 3.2% of the overall annual expenditure of the hospital for personnel.

Conclusion: Headache is highly prevalent among university hospital employees, with significant economic impact.

Citing Articles

Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.

Evers S, Dellagnello G, Novick D, Gonderten H, Panni T, Pascual J Pain Ther. 2024; 13(3):589-607.

PMID: 38625512 PMC: 11111430. DOI: 10.1007/s40122-024-00589-3.

Development and Evaluation of a Smartphone-Based Chatbot Coach to Facilitate a Balanced Lifestyle in Individuals With Headaches (BalanceUP App): Randomized Controlled Trial.

Ulrich S, Gantenbein A, Zuber V, von Wyl A, Kowatsch T, Kunzli H J Med Internet Res. 2024; 26:e50132.

PMID: 38265863 PMC: 10851123. DOI: 10.2196/50132.

Wen Dan Tang: A Potential Jing Fang Decoction for Headache Disorders?.

Pradhan S, Li Y, Gantenbein A, Angst F, Lehmann S, Shaban H Medicines (Basel). 2022; 9(3).

PMID: 35323721 PMC: 8955743. DOI: 10.3390/medicines9030022.

Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China.

Yuan J, Lu Z, Xiong X, Jiang B BMJ Glob Health. 2021; 6(9).

PMID: 34518200 PMC: 8438819. DOI: 10.1136/bmjgh-2021-005519.

An Investigation into the Prevalence of Migraine and Its Prophylactic Treatment Patterns in the Czech Republic: An Observational Study.

Dolezil D, Markova J, Klimes J, Pocikova Z, Dostal F, Stepanova R J Pain Res. 2020; 13:2895-2906.

PMID: 33209057 PMC: 7669514. DOI: 10.2147/JPR.S273119.

References

Rasmussen B . Epidemiology of headache. Cephalalgia. 2001; 21(7):774-7. DOI: 10.1177/033310240102100708. View

Lipton R, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J . A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003; 61(3):375-82. DOI: 10.1212/01.wnl.0000078940.53438.83. View

MacGregor E, Brandes J, Eikermann A . Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache. 2003; 43(1):19-26. DOI: 10.1046/j.1526-4610.2003.03004.x. View

Lipton R, Scher A, Steiner T, Bigal M, Kolodner K, Liberman J . Patterns of health care utilization for migraine in England and in the United States. Neurology. 2003; 60(3):441-8. DOI: 10.1212/wnl.60.3.441. View

Landy S . Migraine throughout the life cycle: treatment through the ages. Neurology. 2004; 62(5 Suppl 2):S2-8. DOI: 10.1212/wnl.62.5_suppl_2.s2. View

Schwartz B, Stewart W, Lipton R . Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med. 1997; 39(4):320-7. DOI: 10.1097/00043764-199704000-00009. View

Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A . The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3):193-210. DOI: 10.1111/j.1468-2982.2007.01288.x. View

Bigal M, Lipton R, Stewart W . The epidemiology and impact of migraine. Curr Neurol Neurosci Rep. 2004; 4(2):98-104. DOI: 10.1007/s11910-004-0022-8. View

. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988; 8 Suppl 7:1-96. View

10.

Morillo L, Alarcon F, Aranaga N, Aulet S, Chapman E, Conterno L . Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries. Headache. 2005; 45(2):118-26. DOI: 10.1111/j.1526-4610.2005.05025.x. View

11.

Linde M, Gustavsson A, Stovner L, Steiner T, Barre J, Katsarava Z . The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2011; 19(5):703-11. DOI: 10.1111/j.1468-1331.2011.03612.x. View

12.

Berg J, Stovner L . Cost of migraine and other headaches in Europe. Eur J Neurol. 2005; 12 Suppl 1:59-62. DOI: 10.1111/j.1468-1331.2005.01192.x. View

13.

Kobak K, Katzelnick D, Sands G, King M, Greist J, Dominski M . Prevalence and burden of illness of migraine in managed care patients. J Manag Care Pharm. 2005; 11(2):124-36. PMC: 10437341. DOI: 10.18553/jmcp.2005.11.2.124. View

14.

Burton W, Conti D, Chen C, Schultz A, Edington D . The economic burden of lost productivity due to migraine headache: a specific worksite analysis. J Occup Environ Med. 2002; 44(6):523-9. DOI: 10.1097/00043764-200206000-00013. View

15.

Diener H, Limmroth V . Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004; 3(8):475-83. DOI: 10.1016/S1474-4422(04)00824-5. View

16.

Solomon G, Price K . Burden of migraine. A review of its socioeconomic impact. Pharmacoeconomics. 1996; 11 Suppl 1:1-10. DOI: 10.2165/00019053-199700111-00003. View

17.

Holmes W, MacGregor E, Dodick D . Migraine-related disability: impact and implications for sufferers' lives and clinical issues. Neurology. 2001; 56(6 Suppl 1):S13-9. DOI: 10.1212/wnl.56.suppl_1.s13. View

18.

Russell M, Levi N, Saltyte-Benth J, Fenger K . Tension-type headache in adolescents and adults: a population based study of 33,764 twins. Eur J Epidemiol. 2006; 21(2):153-60. DOI: 10.1007/s10654-005-6031-3. View

19.

Raak R, Raak A . Work attendance despite headache and its economic impact: a comparison between two workplaces. Headache. 2003; 43(10):1097-101. DOI: 10.1046/j.1526-4610.2003.03212.x. View

20.

Lipton R, Stewart W, Sawyer J, EDMEADS J . Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001; 41(9):854-61. View